Search

Author/Creator Kuruvilla, Denison

2. Fatal capillary leak syndrome in a child with acute lymphoblastic leukemia treated with moxetumomab pasudotox for pre‐transplant minimal residual disease reduction. Issue 1 (22nd September 2020)

Authors:
Shah, Nirali N.; Schneiderman, Jennifer; Kuruvilla, Denison; Bhojwani, Deepa; Fry, Terry J.; Martin, Paul L.; Schultz, Kirk R.; Silverman, Lewis B.; Whitlock, James A.; Wood, Brent; Vainshtein, Inna; Adams, Alexia; Confer, Dennis; Pulsipher, Michael A.; Chaudhury, Sonali; Wayne, Alan S.
Journal:
Pediatric blood & cancer
Issue:
Volume 68:Issue 1(2021)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Human Relaxin-2 Fusion for the Treatment of Heart Failure. (November 2018)

Authors:
Hao, Weidong; Garcia, Andrew; Muniz-Medina, Vanessa; Sadowska, Agnieszka; Chen, Ruoyan; Paterson, Judy; Papworth, Monika; Lin, Jia; Xu, Linda; Kuruvilla, Denison; Pao, Diana; Karathanasis, Sotirios; Gao, Changshou; Rosenthal, Kim; Rickert, Keith; Wilson, Susan; Osbourn, Jane; Walker, Jill
Journal:
Journal of molecular and cellular cardiology
Issue:
Volume 124(2018)
Page Start:
115
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Human Relaxin‐2 Fusion Protein Treatment Prevents and Reverses Isoproterenol‐Induced Hypertrophy and Fibrosis in Mouse Heart. Issue 24 (17th December 2019)

Authors:
Sun, Junhui; Hao, Weidong; Fillmore, Natasha; Ma, Hanley; Springer, Danielle; Yu, Zu‐Xi; Sadowska, Agnieszka; Garcia, Andrew; Chen, Ruoyan; Muniz‐Medina, Vanessa; Rosenthal, Kim; Lin, Jia; Kuruvilla, Denison; Osbourn, Jane; Karathanasis, Sotirios K.; Walker, Jill; Murphy, Elizabeth
Journal:
Journal of the American Heart Association
Issue:
Volume 8:Issue 24(2019)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Pharmacokinetics, pharmacodynamics, and safety of subcutaneous anifrolumab in patients with systemic lupus erythematosus, active skin disease, and high type I interferon gene signature: a multicentre, randomised, double-blind, placebo-controlled, phase 2 study. (February 2021)

Authors:
Bruce, Ian N; Nami, Alireza; Schwetje, Erik; Pierson, M Edward; Rouse, Tomas; Chia, Yen Lin; Kuruvilla, Denison; Abreu, Gabriel; Tummala, Raj; Lindholm, Catharina
Journal:
Lancet
Issue:
Volume 3:Number 2(2021)
Page Start:
e101
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Population pharmacokinetics, efficacy, and safety of moxetumomab pasudotox in patients with relapsed or refractory hairy cell leukaemia. Issue 7 (16th March 2020)

Authors:
Kuruvilla, Denison; Chia, Yen Lin; Balic, Kemal; Yao, Nai Shun; Kreitman, Robert J.; Pastan, Ira; Li, Xia; Standifer, Nathan; Liang, Meina; Tseng, Chih‐Ming; Faggioni, Raffaella; Roskos, Lorin
Journal:
British journal of clinical pharmacology
Issue:
Volume 86:Issue 7(2020)
Page Start:
1367
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗